4//SEC Filing
Thompson Kimberly Kraig 4
Accession 0001493152-22-020038
CIK 0001413119other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:30 PM ET
Size
6.9 KB
Accession
0001493152-22-020038
Insider Transaction Report
Form 4
Thompson Kimberly Kraig
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2022-07-19−50,000→ 201,707,924 total - Sale
Common Stock
2022-07-20−120,000→ 201,587,924 total
Footnotes (3)
- [F1]These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on July 19, 2022 at $0.0647.
- [F2]These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on July 20, 2022 at $0.0712.
- [F3]Includes 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson, and the remainder consists of common stock Mr. Thompson owns.
Documents
Issuer
Kraig Biocraft Laboratories, Inc
CIK 0001413119
Entity typeother
Related Parties
1- filerCIK 0001837586
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 4:30 PM ET
- Size
- 6.9 KB